Literature DB >> 7897259

Murine AIDS: a model for the human disease or a distinct entity?

R K Cunnigham1, H R Thacore, P Zhou, R Terzian, S Nakeeb, M B Zaleski.   

Abstract

The LP-BM5 mixture of murine retroviruses elicits a disease in mice referred to as murine immunodeficiency syndrome (MAIDS) that is considered by some to be an animal homologue of human AIDS. In this article, we present and discuss some recent findings on the pathogenesis of the murine disease and their implications for the proposed homology between murine and human syndromes. The murine disease seems to display as many similarities to as it does differences from human AIDS. Among the latter are: definitive and exclusive viral etiology, a strong genetic effect on susceptibility to infection, expansion of the CD4+ cell population in spleen and peripheral blood, consistent transmissibility by a single transfusion of the minute amounts of blood or plasma from infected donors, and striking similarity between virus-induced alteration of the in vitro spleen cell proliferation and those caused by treatment with a protein kinase inhibitor K252a. With this in mind, the use of the noncommittal term retrovirus-induced murine lymphoproliferative disease instead of MAIDS appears to be more appropriate at this time.

Entities:  

Mesh:

Year:  1994        PMID: 7897259     DOI: 10.1007/bf02918221

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  31 in total

1.  Characteristics and contributions of defective, ecotropic, and mink cell focus-inducing viruses involved in a retrovirus-induced immunodeficiency syndrome of mice.

Authors:  S K Chattopadhyay; D N Sengupta; T N Fredrickson; H C Morse; J W Hartley
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Reduced CD4 + T cells and severe oral candidiasis in absence of HIV infection.

Authors:  C Pankhurst; M Peakman
Journal:  Lancet       Date:  1989-03-25       Impact factor: 79.321

Review 3.  Animal models for retrovirus-induced immunodeficiency disease.

Authors:  D E Mosier
Journal:  Immunol Invest       Date:  1986-05       Impact factor: 3.657

4.  Did Moriz Kaposi describe AIDS in 1872?

Authors:  L H Breimer
Journal:  Clio Med       Date:  1984

Review 5.  Potential pitfalls on the road to an effective HIV vaccine.

Authors:  D H Schwartz
Journal:  Immunol Today       Date:  1994-02

6.  In vitro proliferation of murine spleen cells: genetic control of proliferative responses induced by phorbol ester and calcium ionophore A23187.

Authors:  P Zhou; L J Quackenbush; B Albini; M B Zaleski
Journal:  Immunobiology       Date:  1989-11       Impact factor: 3.144

7.  Acquired immunodeficiency in murine lymphoproliferative disease: considerations on pathogenesis.

Authors:  H R Thacore; R K Cunningham; P Zhou; S Nakeeb; R Terzian; M B Zaleski
Journal:  Immunobiology       Date:  1994-04       Impact factor: 3.144

8.  Modulation of antigen-presenting capacity of human monocytes by HIV-1 GP120 molecule fragments.

Authors:  M Zembala; J Pryjma; A Płucienniczak; A Szczepanek; I Ruggiero; M Jasiński; V Colizzi
Journal:  Immunol Invest       Date:  1994-04       Impact factor: 3.657

9.  Plaque Formation in Agar by Single Antibody-Producing Cells.

Authors:  N K Jerne; A A Nordin
Journal:  Science       Date:  1963-04-26       Impact factor: 47.728

10.  Retroviral induction of acute lymphoproliferative disease and profound immunosuppression in adult C57BL/6 mice.

Authors:  D E Mosier; R A Yetter; H C Morse
Journal:  J Exp Med       Date:  1985-04-01       Impact factor: 14.307

View more
  2 in total

1.  Cryptococcus neoformans infection in mice previously infected with LP-BM5 MuLV, the agent of murine AIDS (MAIDS).

Authors:  C Lacroix; F Chau; C Carbon; M Sinet; F Derouin
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

Review 2.  SOCS and Herpesviruses, With Emphasis on Cytomegalovirus Retinitis.

Authors:  Christine I Alston; Richard D Dix
Journal:  Front Immunol       Date:  2019-04-11       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.